loader from loading.io

EPA’s Proposed Registration of a Sprayable RNAi Biopesticide — A Conversation with Meibao Zhuang, Ph.D.

All Things Chemical

Release Date: 12/14/2023

What to Expect from The 119th Congress — A Conversation with Mark Washko show art What to Expect from The 119th Congress — A Conversation with Mark Washko

All Things Chemical

This week I discuss with my colleague, , Senior Government Affairs Advisor for B&C and The Acta Group, our consulting affiliate, the new 119th Congress and what might be key legislative actions our listeners should look for. The new Congress reflects many new members, new staffs, and a new Republican majority in both chambers. What can we expect? Will Congressional Review Act measures un-do key Biden initiatives? What might we expect in terms of a budget reconciliation package? These issues and a whole lot more are the subject of my conversation with Mark. ALL MATERIALS IN THIS PODCAST ARE...

info_outline
EPA Final Rule — A Conversation with Richard E. Engler, Ph.D. show art EPA Final Rule — A Conversation with Richard E. Engler, Ph.D.

All Things Chemical

Recognizing it has much to do and little time to complete its tasks, the Office of Pollution Prevention and Toxics (OPPT) has been issuing final rules at a fast and furious rate since the election last month. This week, I discuss OPPT’s to-do list with my colleague, , Director of Chemistry for B&C and The Acta Group (Acta®), our consulting affiliate. In addition to multiple final Section 6 risk management rules, the U.S. Environmental Protection Agency (EPA) has also issued final revisions to its new chemicals review process and a Section 8(d) rule. We conclude with Rich’s thoughts on...

info_outline
Election Outcome — A Conversation with James V. Aidala and Mark J. Washko show art Election Outcome — A Conversation with James V. Aidala and Mark J. Washko

All Things Chemical

This week, I sat down with our two government affairs experts, and , to get their take on the very eventful past two weeks and seek their thoughts on what 2025 might look like legislatively and at the U.S. Environmental Protection Agency (EPA) administratively. With the Republican trifecta and some surprising Cabinet and EPA-designate picks, we have much to discuss. We cover the election results, the transition period between now and Inauguration Day, and then speculate on the remainder of 2025, a year that promises to be like no other. ALL MATERIALS IN THIS PODCAST ARE PROVIDED SOLELY FOR...

info_outline
GLP Case Studies/Lessons Learned  — A Conversation with Lara Hall show art GLP Case Studies/Lessons Learned — A Conversation with Lara Hall

All Things Chemical

This week, I welcomed to the studio , Senior Regulatory Scientist/Quality Assurance Specialist at B&C and our consulting affiliate, The Acta Group (Acta®), to discuss a few of the many critical issues associated with chemical testing. Chemical testing is undertaken for lots of reasons: government mandate; product stewardship; and product defense and support, to name a few. What is under-appreciated is the importance of the standards that apply under Good Laboratory Practices (GLP), the expertise needed to address novel testing approaches that deviate from GLP, how to manage requests from...

info_outline
A Conversation with Deputy Commissioner Jim Jones show art A Conversation with Deputy Commissioner Jim Jones

All Things Chemical

This week I had the pleasure of speaking with U.S. Food and Drug Administration (FDA) Deputy Commissioner for Human Foods, , about all the amazing initiatives Jim is overseeing as the first FDA Deputy Commissioner for Human Foods. Many of us in the chemical community know Jim and his extraordinary career at the U.S. Environmental Protection Agency (EPA) leading both the EPA pesticides and toxics program offices, culminating his EPA career as Assistant Administrator for Toxics in the Obama Administration. Jim’s keen understanding of the administrative, chemical prioritization, risk...

info_outline
A Conversation with Linda Reinstein, President and Cofounder of the Asbestos Disease Awareness Organization (ADAO) show art A Conversation with Linda Reinstein, President and Cofounder of the Asbestos Disease Awareness Organization (ADAO)

All Things Chemical

This week I had the pleasure of speaking with , President and Cofounder of the Asbestos Disease Awareness Organization (ADAO), about her many years of asbestos disease awareness advocacy. Having lost her husband, Alan, to mesothelioma two decades ago, Linda set out to educate others about the diseases associated with asbestos exposure. Her story is one of grit, perseverance, and devotion. ALL MATERIALS IN THIS PODCAST ARE PROVIDED SOLELY FOR INFORMATIONAL  AND ENTERTAINMENT PURPOSES. THE MATERIALS ARE NOT INTENDED TO CONSTITUTE LEGAL ADVICE OR THE PROVISION OF LEGAL SERVICES. ALL LEGAL...

info_outline
TSCA Reform: Eight Years Later  — Panel 4: Shaping the Agenda, Section 21 Citizens’ Petitions and Other Mechanisms Influencing Priority Setting show art TSCA Reform: Eight Years Later — Panel 4: Shaping the Agenda, Section 21 Citizens’ Petitions and Other Mechanisms Influencing Priority Setting

All Things Chemical

On June 26, 2024, B&C, along with the Environmental Law Institute and the George Washington University Milken Institute of Public Health, sponsored the all-day virtual conference, . The quality of the discussion, the caliber of the participants, and the timeliness of the content motivated us to repurpose the substantive sessions. B&C and ELI are pleased to co-sponsor this episode of All Things Chemical® to enable our podcast audience to listen to these sessions. Lynn L. Bergeson moderated Panel 4: Shaping the Agenda: Section 21 Citizens’ Petitions and Other Mechanisms...

info_outline
TSCA Reform: Eight Years Later  — Panel 3: New Chemical Review show art TSCA Reform: Eight Years Later — Panel 3: New Chemical Review

All Things Chemical

On June 26, 2024, B&C, along with the Environmental Law Institute and the George Washington University Milken Institute of Public Health, sponsored the all-day virtual conference, . The quality of the discussion, the caliber of the participants, and the timeliness of the content motivated us to repurpose the substantive sessions. B&C and ELI are pleased to co-sponsor this episode of All Things Chemical® to enable our podcast audience to listen to these sessions. Samantha Liskow, Lead Counsel, Health Program, EDF, moderated Panel 3: New Chemical Review. The panelists included...

info_outline
TSCA Reform: Eight Years Later  — Panel 2: Risk Evaluation and the Supporting Role Sections 4 and 8 Play show art TSCA Reform: Eight Years Later — Panel 2: Risk Evaluation and the Supporting Role Sections 4 and 8 Play

All Things Chemical

On June 26, 2024, B&C, along with the Environmental Law Institute and the George Washington University Milken Institute of Public Health, sponsored the all-day virtual conference, . The quality of the discussion, the caliber of the participants, and the timeliness of the content motivated us to repurpose the substantive sessions. B&C and ELI are pleased to co-sponsor this episode of All Things Chemical® to enable our podcast audience to listen to these sessions. Maria J. Doa, Ph.D., Senior Director, Chemicals Policy, Environmental Defense Fund (EDF), moderated Panel 2: Risk...

info_outline
TSCA Reform: Eight Years Later  — Panel 1: Risk Management show art TSCA Reform: Eight Years Later — Panel 1: Risk Management

All Things Chemical

On June 26, 2024, B&C, along with the Environmental Law Institute and the George Washington University Milken Institute of Public Health, sponsored the all-day virtual conference, . The quality of the discussion, the caliber of the participants, and the timeliness of the content motivated us to repurpose the substantive sessions. B&C and ELI are pleased to co-sponsor this episode of All Things Chemical® to enable our podcast audience to listen to these sessions. Karyn M. Schmidt, Senior Director, Regulatory & Scientific Affairs, American Chemistry Council, moderated Panel 1:...

info_outline
 
More Episodes

This week, listeners are in for a real treat as I sit down with Dr. Meibao Zhuang, Senior Scientist/Regulatory Consultant with B&C and our consulting affiliate, The Acta Group, to discuss double-stranded ribonucleic acid interference, better known as ds RNAi. Ds RNAi is a technology that allows scientists to silence (or interfere with) a particular gene. In the agricultural sector, this genetic modification can be used to great advantage to control pests of all sorts with extreme precision. Meibao will discuss EPA’s proposed registration of the first sprayable RNAi biopesticide and the exciting implications of this technology.

ALL MATERIALS IN THIS PODCAST ARE PROVIDED SOLELY FOR INFORMATIONAL  AND ENTERTAINMENT PURPOSES. THE MATERIALS ARE NOT INTENDED TO CONSTITUTE LEGAL ADVICE OR THE PROVISION OF LEGAL SERVICES. ALL LEGAL QUESTIONS SHOULD BE ANSWERED DIRECTLY BY A LICENSED ATTORNEY PRACTICING IN THE APPLICABLE AREA OF LAW.

©2023 Bergeson & Campbell, P.C.  All Rights Reserved